New BA.2.86 COVID-19 Variant Detected in Israel, Raises Concerns Over Vaccine Efficacy
Israel Reports Emergence of BA.2.86 COVID-19 Variant; Vaccine Effectiveness Under Scrutiny
Table of Contents (Show / Hide)
Reports from local media in Israel reveal the identification of a novel COVID-19 variant named BA.2.86 within the country, as confirmed by the Israel Public Broadcasting Organization (KAN) on Sunday.
This development marks the first instance of the BA.2.86 variant being detected in Israel and the fourth case worldwide. Previous occurrences of this variant were reported in the United States, the United Kingdom, and Denmark.
The distinctive feature of the BA.2.86 variant lies in its significant accumulation of mutations. This characteristic has prompted concerns about its potential to undermine the efficacy of existing vaccines. The World Health Organization (WHO) has also expressed apprehension over the emergence of this variant, highlighting the need for further scrutiny and investigation.
The WHO had earlier categorized the BA.2.86 variant as a "variant under monitoring," a classification that reflects the attention drawn to it due to the multitude of mutations it carries. As the global effort to combat the pandemic continues, the implications of this new variant on vaccine effectiveness and public health strategies remain a subject of active research and concern.
URL :
News ID : 2406
10 Effective Home Remedies for Teeth Whitening
15 Foods to Lower Cholesterol Levels
More than a billion teens and young people risk hearing loss due to use of headphones, earbuds
Diseases That Will Kill You the Quickest
FDA approves Pfizer, Moderna COVID-19 booster shots in US
Major sports events of 2022
Intensifying ethnic polarity in Israel reaches deadline of election campaign
Nakba 75: Palestinian citizens of Israel are exiles in their own land
10 Reasons to Start business in Dubai
Most satisfying Jobs in 2023!
